Highland Capital Partners VII LP
CIK 0001343678 Name as filed on the most recent filing
Filed as Highland Capital Partners VII LP (12)
68 transaction lines · from 12 filings · filed 2012-08-02 to 2021-08-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER ThredUp Inc. 1 filings
- ISSUER Gigamon Inc. 2 filings
- ISSUER Hyperion Therapeutics Inc 9 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2021-08-02 |
ThredUp Inc. TDUP |
S, Open-market sale | 229,293 disposed | 23.16 | 5,310,150.73 | Form 4, filing 0001484778-21-000051 | |
| 2021-08-02 |
ThredUp Inc. TDUP |
S, Open-market sale | 80,916 disposed | 23.16 | 1,873,917.46 | Form 4, filing 0001484778-21-000051 | |
| 2021-08-02 |
ThredUp Inc. TDUP |
S, Open-market sale | 55,562 disposed | 23.16 | 1,286,749.25 | Form 4, filing 0001484778-21-000051 | |
| 2021-08-02 |
ThredUp Inc. TDUP |
S, Open-market sale | 7,185 disposed | 23.16 | 166,395.98 | Form 4, filing 0001484778-21-000051 | |
| 2013-10-28 |
Gigamon Inc. GIMO |
S, Open-market sale | 1,131,444 disposed | 38.50 | 43,560,594.00 | Form 4, filing 0001104659-13-078404 | |
| 2013-10-28 |
Gigamon Inc. GIMO |
S, Open-market sale | 399,279 disposed | 38.50 | 15,372,241.50 | Form 4, filing 0001104659-13-078404 | |
| 2013-10-28 |
Gigamon Inc. GIMO |
S, Open-market sale | 274,171 disposed | 38.50 | 10,555,583.50 | Form 4, filing 0001104659-13-078404 | |
| 2013-10-28 |
Gigamon Inc. GIMO |
S, Open-market sale | 35,453 disposed | 38.50 | 1,364,940.50 | Form 4, filing 0001104659-13-078404 | |
| 2013-09-20 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 2,643 disposed | 25.81 | 68,215.83 | Form 4, filing 0001104659-13-071668 | |
| 2013-09-20 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 933 disposed | 25.81 | 24,080.73 | Form 4, filing 0001104659-13-071668 | |
| 2013-09-20 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 641 disposed | 25.81 | 16,544.21 | Form 4, filing 0001104659-13-071668 | |
| 2013-09-20 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 83 disposed | 25.81 | 2,142.23 | Form 4, filing 0001104659-13-071668 | |
| 2013-09-19 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 894 disposed | 25.93 | 23,181.42 | Form 4, filing 0001104659-13-071668 | |
| 2013-09-19 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 315 disposed | 25.93 | 8,167.95 | Form 4, filing 0001104659-13-071668 | |
| 2013-09-19 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 217 disposed | 25.93 | 5,626.81 | Form 4, filing 0001104659-13-071668 | |
| 2013-09-19 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 28 disposed | 25.93 | 726.04 | Form 4, filing 0001104659-13-071668 | |
| 2013-09-18 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 3,547 disposed | 26.03 | 92,328.41 | Form 4, filing 0001104659-13-071134 | |
| 2013-09-18 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 1,252 disposed | 26.03 | 32,589.56 | Form 4, filing 0001104659-13-071134 | |
| 2013-09-18 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 860 disposed | 26.03 | 22,385.80 | Form 4, filing 0001104659-13-071134 | |
| 2013-09-18 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 111 disposed | 26.03 | 2,889.33 | Form 4, filing 0001104659-13-071134 | |
| 2013-09-17 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 6,009 disposed | 25.99 | 156,173.91 | Form 4, filing 0001104659-13-071134 | |
| 2013-09-17 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 2,121 disposed | 25.99 | 55,124.79 | Form 4, filing 0001104659-13-071134 | |
| 2013-09-17 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 1,456 disposed | 25.99 | 37,841.44 | Form 4, filing 0001104659-13-071134 | |
| 2013-09-17 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 188 disposed | 25.99 | 4,886.12 | Form 4, filing 0001104659-13-071134 | |
| 2013-09-16 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 3,812 disposed | 26.22 | 99,950.64 | Form 4, filing 0001104659-13-070475 | |
| 2013-09-16 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 1,345 disposed | 26.22 | 35,265.90 | Form 4, filing 0001104659-13-070475 | |
| 2013-09-16 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 924 disposed | 26.22 | 24,227.28 | Form 4, filing 0001104659-13-070475 | |
| 2013-09-16 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 119 disposed | 26.22 | 3,120.18 | Form 4, filing 0001104659-13-070475 | |
| 2013-09-13 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 1,291 disposed | 26.50 | 34,211.50 | Form 4, filing 0001104659-13-070475 | |
| 2013-09-13 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 456 disposed | 26.50 | 12,084.00 | Form 4, filing 0001104659-13-070475 | |
| 2013-09-13 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 313 disposed | 26.50 | 8,294.50 | Form 4, filing 0001104659-13-070475 | |
| 2013-09-13 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 40 disposed | 26.50 | 1,060.00 | Form 4, filing 0001104659-13-070475 | |
| 2013-09-11 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 2,812 disposed | 27.08 | 76,148.96 | Form 4, filing 0001104659-13-069607 | |
| 2013-09-11 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 992 disposed | 27.08 | 26,863.36 | Form 4, filing 0001104659-13-069607 | |
| 2013-09-11 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 681 disposed | 27.08 | 18,441.48 | Form 4, filing 0001104659-13-069607 | |
| 2013-09-11 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 88 disposed | 27.08 | 2,383.04 | Form 4, filing 0001104659-13-069607 | |
| 2013-09-10 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 18,444 disposed | 26.48 | 488,397.12 | Form 4, filing 0001104659-13-069607 | |
| 2013-09-10 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 6,509 disposed | 26.48 | 172,358.32 | Form 4, filing 0001104659-13-069607 | |
| 2013-09-10 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 4,469 disposed | 26.48 | 118,339.12 | Form 4, filing 0001104659-13-069607 | |
| 2013-09-10 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 578 disposed | 26.48 | 15,305.44 | Form 4, filing 0001104659-13-069607 | |
| 2013-09-09 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 11,034 disposed | 26.06 | 287,546.04 | Form 4, filing 0001104659-13-069051 | |
| 2013-09-09 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 3,894 disposed | 26.06 | 101,477.64 | Form 4, filing 0001104659-13-069051 | |
| 2013-09-09 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 2,674 disposed | 26.06 | 69,684.44 | Form 4, filing 0001104659-13-069051 | |
| 2013-09-09 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 346 disposed | 26.06 | 9,016.76 | Form 4, filing 0001104659-13-069051 | |
| 2013-09-06 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 61 disposed | 25.50 | 1,555.50 | Form 4, filing 0001104659-13-069051 | |
| 2013-09-06 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 22 disposed | 25.50 | 561.00 | Form 4, filing 0001104659-13-069051 | |
| 2013-09-06 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 15 disposed | 25.50 | 382.50 | Form 4, filing 0001104659-13-069051 | |
| 2013-09-06 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 2 disposed | 25.50 | 51.00 | Form 4, filing 0001104659-13-069051 | |
| 2013-08-05 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 15,369 disposed | 25.48 | 391,602.12 | Form 4, filing 0001104659-13-061036 | |
| 2013-08-05 |
Hyperion Therapeutics Inc HPTX |
S, Open-market sale | 5,424 disposed | 25.48 | 138,203.52 | Form 4, filing 0001104659-13-061036 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Highland Capital Partners VII LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001343678
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6